Molecular Medicine Partnership Unit Medical Campus of the University of Heidelberg, Germany. Research themes place emphasis on common diseases, particularly blood disorders, cancer, iron metabolism disorders, chronic pain, diseases associated with aging, and AIDS. In 2018 more than 110 scientists from across the world work on these eight research themes: Molecular Medicine Partnership Unit The Molecular Medicine Partnership Unit (MMPU) is an alliance between the European Molecular Biology Laboratory (EMBL) and the Medical Faculty of the University of Heidelberg. Its primary aim is to uncover the molecular basis of disease and to speed the transformation of biomedical discoveries into personalized medicine strategies. Founded in
Ethics of technology how to treat diseases and provide families in need with the resources to cope. A version of pre-natal testing, called tandem mass spectrometry, is a procedure that "measures levels and patterns of numerous metabolites in a single drop of blood, which are then used to identify potential diseases. Using this same drop of blood, tandem mass spectrometry enables the detection of at least four times the number of disorders than was possible with previous technologies." This allows for a cost-effective and fast method of pre-natal testing. However, critics of tandem mass spectrometry and technologies like it are concerned about the